RxDoctor Payments Data

Tiffany Reed

Geriatric Medicine · Greensboro, NCNPI 1114135522

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Amgen at 35.6% of the total. Reporting peaked in 2019 at $935 and has fallen 83.8% since, to $151 in 2025. Among geriatric medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,246in general payments, 2019–2025

Across 109 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$798
  • Avanir Pharmaceuticals, Inc.$295
  • Boehringer Ingelheim$239
  • Pfizer$223
  • Lilly USA, LLC$185
  • AstraZeneca$122
  • plus $383 from 13 others

What the payments were for

  • Food & beverage$2,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,246 in reported general payments places this provider in the 90th percentile of 138 geriatric medicine providers in North Carolina.

See all geriatric medicine providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate17$43,164
MyrbetriqMirabegron137$41,781
EliquisApixaban104$38,709
TrulicityDulaglutide24$24,258
RybelsusSemaglutide22$22,667
OzempicSemaglutide22$22,653
XareltoRivaroxaban30$15,609
ElmironPentosan Polysulfate Sodium13$13,940
InvokanaCanagliflozin15$11,323
Cinacalcet Hcl11$10,322
RexultiBrexpiprazole14$9,841
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,127
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,944
Repatha PushtronexEvolocumab13$8,186
Atorvastatin Calcium206$7,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$223$38,709104 claims
Lilly USA, LLCTrulicity$185$24,25824 claims
Boehringer IngelheimCombivent Respimat, Tradjenta$239$11,40323 claims
AstraZenecaBreztri Aerosphere$122$8,94413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 138 geriatric medicine providers in North Carolina.

Other geriatric medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →